SGLT-2 inhibitors, initially developed for type 2 diabetes, demonstrate profound cardiorenal and metabolic benefits. This review synthesizes evidence from clinical trials and mechanistic studies to ...
The number of Finns working remotely from their summer cottages has declined compared to the peak of the Covid era, according to a survey by the Finnish Leisure Homeowners' Association (Vaal). This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback